Concert Pharma Gets 2nd FTC Request Over Vertex Deal

Massachusetts-based Concert Pharmaceuticals Inc. has received a second request for information from the Federal Trade Commission for the planned sale of its investigational cystic fibrosis treatment to Vertex Pharmaceuticals Inc. in...

Already a subscriber? Click here to view full article